5th International Congress of the International Living Donor – Liver Transplantation Group

5th International Congress of the International Living Donor – Liver Transplantation Group 

Organised by the INTERNATIONAL LIVING DONOR LIVER TRANSPLANTATION GROUP

in collaboration with the Belgian Liver-Intestine Committee [BELIAC] of the Belgian Transplantation Society [BTS]
and the Belgian Section for Hepatobiliary and Pancreatic Surgery (BSHBPS) of the Royal Belgian Society of Surgery [RBSS.]

Endorsed by ESOT, ELITA, ELTR, ILTS, ISLS, ILLS, UEMS-EBTS, ACHBT, HEPATOTRANSPLANT BRUSSELS, EUROLIVER FOUNDATION

Learn about the learning outcome here

CONGRESS DESCRIPTION

This congress aims to give a comprehensive review and update about living donor liver transplantation (LDLT) and advanced hepatobiliary surgery. The congress banner ‘Excellence through versatility’ reflects the enormous evolution that have been made in ths field of surgery, transplantation surgery and medicine since it’s first applications in clinical practice by Professors R.STRONG(1989) and K.TANAKA (1990) and Professor M.MAKUUCHI (1990). The 90’s were the years of exploring technical and ethical feasibility (“nihil nocere”) : “the allograft morphology and anatomy matter “ The 00’s were the years of exploring functional boundaries by perfecting surgical skills and imaging (“small for size graft and syndrome”) : “the allograft morphology and function
matter”; The 10’s were the years of exploring innovative surgical and immunologic techniques to enhance donor and recipient safety and to widen the clinical indications; “ the donor’s safety and quality of life matter” The 20’s will be the years of transplant oncology and minimal invasive donor surgery; “the donor’s scar and agression matter” as well as of continuous cross-fertilisation between liver transplantation and (advanced) liver surgery These evolutionary steps reveal that successful LDLT not only needs “excellence through innovation and integration” (this was the congress banner of the 4th ILDLT Congress in
Kaohsiung,Taiwan) but also “versatlity”. How to cope with unforeseen, pre- or intraoperative, difficullties difficulties needs knowledge, experience and flexibility. Without any doubt modern hepatobiliary surgery has taken profit from the “crossfertilisation” between liver surgery, living donor hepatectomy and liver transplantation. In
order to optimize the treatment of liver diseased patients an interplay between liver surgeons and liver transplant surgeons must be developped in order to get acquainted with each others potentials. Liver resection and liver transplantation should not any longer been seen as competitors but as collaborators! For these reasons several sessions related to implementation of modern technology, to advanced liver surgery and to hepatobiliary oncology have been included in the program. An international, transcontinental and both Eastern and Western, top-faculty will gather in Brussels to deal with almost all aspects, including the treatment of complications, of LDLT and advanced liver surgery.


GOALS AND OBJECTIVES

To learn the liver transplantation community about the actual state of LDLT.This meeting is also meant to foster the development of LDLT in the Western world and so to expand it’s usage especially in the field of hepatobiliary oncology. Indeed LDLT represents the only modality to allow a substantial increase of liver allograft pool.

To improve technical skills of every hepatobiliary surgeon in relation to biliary and especially vascular recontructions. To sensitize hepatobiliary surgeons for the potential of liver transplantation in the  field of oncology


LEARNER OUTCOMES

Update the knowledge about:
– LDLT and extended liver surgery.
– different types of living donor hepatectomy and alternative transplantation techniques;
– extended liver resection surgery by applying techniques of LDLT and LT.
– implementation of modern technology in liver transplantation and surgery
– learn about ethical problems in LDLT and LT
– the advantages and disadvantages of respectively LDLT/LT and liver resection in the treatment of primary and secondary hepatobiliary tumors
– management of postoperative problems in both donor and recipient
– management of unexpected vascular and biliary problems in LDLT and LT


ACCREDITATION

EACCMEand Belgian accreditation for categoreis 4 and 6 (Ethics) have been requested.

CONGRESS ORGANISATION

The congress is organized by the international Living Donor Liver Transplantation Group [iLDLTG] in collaboration with the Belgian HBP Section of the Royal Belgian Society for Surgery [SHBPS -RBSS].The XXI-rst PostGraduate Course of the HBP Section will be integrated in this congress.

CONGRESS PCO

MCI Group / Brussels Office (www.mci-group.com) lead by Mrs. Isabelle DENIAUD
(isabelle.deniaud@mci-group.com )

Read the welcome address here

 

Dear Members,
Dear Colleagues,
Dear Friends,


It is our great pleasure and honor to invite you to particpate in the 5th
International Congress of the iLDLTGroup that will take place in Brussels Friday October 15 and Saturday 16, 2021.
This event will be organised in collaboration with the Belgian Hepato-BiloPancreatic Section (BHBPS) of the Royal Belgian Society for Surgery (RBSS).
Indeed the XXI-rst, yearly, Postgraduate Course of the BHBPS has been officially integrated in the iLDLT Congress.
The biennial iLDLT meeting follows the very successful previous ones, which took place twice in Seoul (SKr) and once in Dallas(US) and Kaohsiung (Tw). As the Western world still hesitates to embrace this therapeutic modality, the iLDLTG council found it opportune to “export” the congress to Europe.
The program focuses on the spectacular technical advances that have been made during the last two decades in this field of transplantation as well as on the cross-fertilization between living donor liver transplantation and hepatobiliary surgery. The sessions dedicated to hepatobiliary oncology (eg. which patient to resect, which one to transplant) and to advanced liver surgery (eg. in vivo and ex-vivo liver surgery) and modern surgical technology (eg. laparoscopic and robotic liver surgery) clearly illustrate this idea.

The congress aims at capturing the interest of both transplant and nontransplant communities in order to foster progresses in the treatment of benign and malignant hepatobiliary diseases. These progresses are based on “versatility”, indeed the key to be successful in complex surgical procedures and decision making processes !
During this two days meeting, many of the world’s most reknowned, both Western and Eastern, leaders in the fields of (living donor) liver transplantation and hepatobiliary surgery will raise the interest for and the scientific content of this meeting. An occasion not to miss!
The iLDLTG Council and the board of the BHBPS hope to welcome you in October 2021 in ”the heart of Europe”, Brussels.


Mark your calendar already now … and kindly stimulate your surgical and medical colleagues not only to attend, but also to actively participate in the meeting by submitting an abstract. The website of the meeting will be opende soon.


Very sincerely yours,

Prof.em .Jan LERUT
Congress Chair
Past-President iLDLTG
Dr.Alexandra DILI
Congress Co-Chair
President BHBPS-RBSS
Prof. Chao-Long CHEN
President iLDLTG

Read the program here

DAY 1 FRIDAY OCTOBER 15,2021

07.00-07.50 Registration
07.50-08.00 Opening remarks Jan LERUT Leuven (B)
08.00-10.00 SESSION I : A GLOBAL VIEW ON LIVING DONOR LIVER TRANSPLANTATION
08.00-08.15 Europe : report of the ELTRegistry Rene ADAM Paris (Fr)
08.15-08.30 Turkey : the huge effort Selai YILMAZ Malattia (Tr)
08.45-09.00 India : the only way to go? Subhash GUPTA Dehli (In)

teste teste teste